According to court documents, the lawsuits focus on Moderna's use of lipid nanoparticle encapsulation of mRNA vaccines, a technology used to protect the mRNA molecules as they are delivered to ...
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...
Meanwhile, Alnylam has filed suit against both Pfizer/BioNTech and Moderna in the US, alleging that both their vaccines infringe patents it holds on lipid nanoparticles used to deliver them in the ...
Genevant Sciences and Arbutus Biopharma have expanded their patent litigation against Moderna internationally, targeting its lipid nanoparticle technology, which could impact products like ...
3don MSN
Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...
SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company ...
Genevant Sciences and Arbutus Biopharma announced that it has filed five international lawsuits seeking to enforce patents protecting their LNP technology against Moderna, Inc. and certain affiliates.
AZoNano on MSN2d
Reprogramming Liver Immunity: A Lipid Nanoparticle Approach for Pancreatic Cancer TherapyA novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback